OATP-C Activators are a class of chemical compounds designed to modulate the activity of the organic anion-transporting polypeptide C (OATP-C), which is also known as solute carrier organic anion transporter 1C1 (SLCO1C1). OATP-C is a membrane-bound transporter protein found in various tissues, including the liver, brain, and blood-brain barrier. This transporter is responsible for the uptake and transport of a wide range of endogenous and exogenous substrates, including hormones, drugs, and xenobiotics, across cellular membranes. OATP-C Activators are synthesized to selectively interact with OATP-C, enhancing or inhibiting its transport functions, although the specific mechanisms can vary among different compounds within this chemical class.
The activation or modulation of OATP-C by these compounds can influence the cellular uptake and distribution of various molecules, impacting their pharmacokinetics and overall bioavailability. OATP-C is particularly important for the transport of endogenous compounds like bile acids and hormones, as well as a wide array of drugs. By targeting OATP-C, these activators can potentially enhance or inhibit the transport of specific substrates, affecting their absorption, distribution, and elimination. Consequently, OATP-C Activators serve as valuable tools in pharmacology and drug development research, allowing scientists to investigate the role of OATP-C in drug disposition and xenobiotic transport. However, it's essential to note that the specific mechanisms and potential outcomes of OATP-C activation or inhibition may vary depending on the context, the particular substrate, and the compound used within this chemical class, as OATP-C is involved in the transport of diverse molecules with distinct physicochemical properties.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Omeprazole | 73590-58-6 | sc-202265 | 50 mg | $67.00 | 4 | |
Omeprazole, a proton pump inhibitor, may enhance OATP-C expression, potentially through its interactions with liver enzymes and transporters. | ||||||
Clofibrate | 637-07-0 | sc-200721 | 1 g | $33.00 | ||
Clofibrate, a lipid-lowering agent, might induce OATP-C expression as part of its action in modifying lipid transport and metabolism. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone, a corticosteroid, can potentially increase OATP-C levels, possibly through glucocorticoid receptor-mediated mechanisms. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Nifedipine, a calcium channel blocker, might affect OATP-C expression, potentially as part of its broader influence on cellular transport processes. | ||||||
Benzo[a]pyrene | 50-32-8 | sc-257130 | 1 g | $612.00 | 4 | |
Benzo(a)pyrene, a polycyclic aromatic hydrocarbon, may increase OATP-C expression as part of the body's response to environmental toxins. | ||||||
Troglitazone | 97322-87-7 | sc-200904 sc-200904B sc-200904A | 5 mg 10 mg 25 mg | $110.00 $204.00 $435.00 | 9 | |
Troglitazone, a thiazolidinedione, can potentially enhance OATP-C expression, possibly through peroxisome proliferator-activated receptor (PPAR) pathways. | ||||||
Diethylstilbestrol | 56-53-1 | sc-204720 sc-204720A sc-204720B sc-204720C sc-204720D | 1 g 5 g 25 g 50 g 100 g | $71.00 $287.00 $547.00 $1098.00 $2185.00 | 3 | |
Diethylstilbestrol, a synthetic estrogen, can increase OATP-C expression, potentially through estrogen receptor-mediated mechanisms. | ||||||